MHRA reforms, CE mark recognition, and NHS device safeguards

The UK is overhauling its medical device regulatory framework, with the MHRA outlining future regulations that emphasise patient safety while maintaining supply continuity. A major focus is a new consultation on the indefinite recognition of CE‑marked devices in Great Britain, alongside a published timeline of broader regulatory changes. In parallel, NHS policy work on cybersecurity for connected medical devices highlights growing concern over cyber‑physical risks, while industry players like Upperton Pharma seek MHRA approval for advanced sterile manufacturing facilities. Together, these developments signal a tightening yet pragmatic approach to regulation, aiming to support innovation without compromising safety or resilience.